<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/926FCE3B-DFAB-4FE7-9BF8-7372B5AA9514"><gtr:id>926FCE3B-DFAB-4FE7-9BF8-7372B5AA9514</gtr:id><gtr:name>German Cancer Research Center</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:department>Clinical Biochemistry</gtr:department><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/926FCE3B-DFAB-4FE7-9BF8-7372B5AA9514"><gtr:id>926FCE3B-DFAB-4FE7-9BF8-7372B5AA9514</gtr:id><gtr:name>German Cancer Research Center</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/782061A3-DE90-41A1-99C6-5D7B04D245F4"><gtr:id>782061A3-DE90-41A1-99C6-5D7B04D245F4</gtr:id><gtr:name>Prince Felipe Research Centre</gtr:name><gtr:address><gtr:line1>Avda. Autopista del Saler 16</gtr:line1><gtr:line2>Camino de las Moreras</gtr:line2><gtr:region>Outside UK</gtr:region><gtr:country>Spain</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/DB82E043-58D9-4265-86A4-C42C9AC232EC"><gtr:id>DB82E043-58D9-4265-86A4-C42C9AC232EC</gtr:id><gtr:name>VTT Technical Research Centre of Finland</gtr:name><gtr:address><gtr:line1>Tietotie 3</gtr:line1><gtr:line2>P.O.Box 1000</gtr:line2><gtr:region>Outside UK</gtr:region><gtr:country>Finland</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/521E032C-C065-41B2-9CEA-9A06C8BC5312"><gtr:id>521E032C-C065-41B2-9CEA-9A06C8BC5312</gtr:id><gtr:firstName>Antonio</gtr:firstName><gtr:surname>Vidal-Puig</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=BB%2FH002731%2F1"><gtr:id>EF0AAF04-2213-4774-825C-0EA4CE36250D</gtr:id><gtr:title>Role of fatty acid chain length in energy balance and adaptive thermogenesis</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>BB/H002731/1</gtr:grantReference><gtr:abstractText>Food contains different types of fat. There are some suggestions that not all the fats are equal and that there is good and bad fat with respect to their effects in the body. Not too much is known about what fat normally does in the cells of the body. We know that fat can be stored, burned, been sent from one organ to another within the body and more importantly fat are important 'bricks' to build up the different components of the cells. Interestingly not all the fats have the same size, the length of some fats is longer than others and we think that the length of the fat species may be an important determinant whether fat is stored or burn. The best organ to study this is a special type of organ known as brown fat present in children and small animals. This organ can do both, making fat and burning fat so it is the ideal organ to investigate the effect of fat length on these two processes. To study fat length we will investigate the effect of lack and/or excess of Elovl6, a molecule that elongates fat from 12 carbons to 18 carbons. Specifically we propose to investigate: 1) if making fat longer can alter the development of the brown fat organ; b) whether eliminating/increasing the capacity of elongating fat makes the animals fatter/leaner and c) less/more capable of making heat. To that end we will use cells and mice in which we will decrease or increase the capacity to make fat longer and then study the type of fat these animals make using very novel techniques that allow us to know all the types of fats that these animals will have. This information will inform us about which fats are good and which ones are bad and will allow us, for example, to modify the diets of humans and animals to ensure that they have the right type of fats to remain healthy.</gtr:abstractText><gtr:technicalSummary>A fundamental question regarding the fate of cellular lipids, in particular free fatty acids, is how these lipids are targeted to various fates, either oxidation, storage, export, or incorporation into more complex membrane lipid species. In this proposal we aim to investigate if fatty acid chain length may affect the balance of oxidation vs storage in the highly metabolically active tissue, brown adipose tissue. We will primarily investigate the effect of lack of Elovl6, an enzyme responsible for elongating saturated and monounsaturated C12 and longer fatty acids up to C18. Thus the aim of this grant is to investigate the role of fatty acid chain length on control of fatty acid oxidation, focussing specifically on the fatty acid elongase Elovl6. Specifically we propose to investigate: 1) the role of Elovl6 in BAT differentiation, lipogenesis and function in vitro; b) the role of Elovl6 on energy balance and c) the effect of a lack of Elovl6 on maximal thermogenic capacity of BAT. To that end we will use both cellular and genetically modified animal models with a loss/gain of function in Elovl6 to investigate the effect of altered fatty acid chain length on fatty acid oxidation. In vivo models will be characterised using state of the art phenotyping including performing experiments at different temperatures in purposedly built facilities for thermogenic studies. Also we will use a molecular systems biology phenotyping approach using sophisticated lipidomic and transcriptomic profiling integrated into lipid metabolic networks using bioinformatic analysis.</gtr:technicalSummary><gtr:fund><gtr:end>2012-09-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2009-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>513407</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs><gtr:artisticAndCreativeProductOutput><gtr:description>Use of Social Media
TVPLAB TWITTER
https://twitter.com/tvplab?lang=en-gb</gtr:description><gtr:id>9112EBD3-9ECA-4C8A-8D53-0788CE44B9F6</gtr:id><gtr:impact>Creative tool to communicate our science to public</gtr:impact><gtr:outcomeId>56d2d8f17aead1.22784339</gtr:outcomeId><gtr:title>TVPLAB twitter</gtr:title><gtr:type>Creative Writing</gtr:type><gtr:url>https://twitter.com/tvplab?lang=en-gb</gtr:url><gtr:yearFirstProvided>2015</gtr:yearFirstProvided></gtr:artisticAndCreativeProductOutput><gtr:artisticAndCreativeProductOutput><gtr:description>tvp.mrl.ims.cam.ac.uk/</gtr:description><gtr:id>AD0B6FD7-D899-486F-9F5D-702F3A2C2A44</gtr:id><gtr:impact>Much broader reach attracting more visitors</gtr:impact><gtr:outcomeId>5455075cd45308.82073692</gtr:outcomeId><gtr:title>Development of new webb for the TVP lab</gtr:title><gtr:type>Creative Writing</gtr:type><gtr:url>http://www.tvp.mrl.ims.cam.ac.uk/</gtr:url><gtr:yearFirstProvided>2013</gtr:yearFirstProvided></gtr:artisticAndCreativeProductOutput></gtr:artisticAndCreativeProductOutputs><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>German Cancer Research Center</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>Flies as a disease model to study metabolic disease</gtr:description><gtr:id>A5B51BA2-38AE-472E-86C7-7E5B2DA6CB73</gtr:id><gtr:impact>Senyilmaz D, Virtue S, Xu X, Tan CY, Griffin JL, Miller AK, Vidal-Puig A, Teleman AA. Regulation of mitochondrial morphology and function by stearoylation of TFR1. Nature. 2015 Jul 27. doi: 10.1038/nature14601.</gtr:impact><gtr:outcomeId>58b97d594c8467.91167921-1</gtr:outcomeId><gtr:partnerContribution>generation of genetically modified flies mimicking mouse or cell genetic modification.</gtr:partnerContribution><gtr:piContribution>provide hypothesis for validation in flies and also perform experiments in mammalian systems with insights coming from flies.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>CNN interview about LR11</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>6E9DDF8E-68DA-43D0-B739-873ED3FEC566</gtr:id><gtr:impact>New protein could help burn fat faster
By Meera Senthilingam, for CNN
Updated 1109 GMT (1909 HKT) February 1, 2016 
 (CNN)-Research has shown that the fatter your body becomes, the harder it becomes to burn that excess fat. 
As people eat more fat than they burn, the body stores this excess in various parts of the body and as this storage increases, metabolism changes.

However, all is not lost: a recent study by researchers at the University of Cambridge identified one of the proteins underlying this blockage of fat burn. &amp;quot;[This protein] is part of the system in place to help the body store more energy,&amp;quot; says Antonio Vidal-Puig, Professor in Molecular Nutrition and Metabolism, who worked on the study. 

The culprit, called sLR11, was found to block the functioning of brown fat cells -- responsible for generating heat to keep us warm -- and instead help the body store fat more efficiently by preventing excessive heat generation. 


The benefits of brown fat








There are two forms of fat cells -- brown cells and white cells -- and each plays a different role in our metabolism. 



While brown cells help generate heat, the white cells are responsible for the storage of fat -- or energy -- ready for release as needed. Levels of brown fat are known to be high in children but recent findings showing the presence of brown fat in adults, restored hope to use them as targets to treat obesity.

 

According to Vidal-Puig, obese people have less brown fat than lean people -- and the same applies for diabetics. &amp;quot;If you can increase the brown fat in obese and diabetic people then you can improve their situation,&amp;quot; says Vidal-Puig. This has been known for some time, but making it a reality has been a challenge.

The newly discovered sLR11 protein could provide the answer.


Removing the brakes


Vidal-Puig compares the protein to the brake of a car, stopping the body from accelerating its production of heat. &amp;quot;Obese people have more of these brakes, preventing them from creating heat and therefore losing fat,&amp;quot; says Vidal-Puig who has seen elevated levels of the protein in the blood of obese people included in his study. 

During the study, the team removed the gene producing this protein in mice and found they were able to burn calories faster. 

The researchers went on to examine the protein in humans and found that levels of the protein correlated with the total fat mass in a person. What's more, investigated levels in obese patients after they underwent bariatric surgery, and their weight loss was directly proportional to the decrease in levels of the sLR11 protein.

&amp;quot;[Brown fat cells] are an attractive therapeutic target for weight loss, and for anti-obesity or anti-type 2 Diabetes (T2D) therapies,&amp;quot; says Carole Sztalryd, Associate Professor of Medicine at the University of Maryland School of Medicine. Sztalryd's team also work on biological approaches to weight loss.


More brown than white on the cards


A common focus to tackle obesity has been on accelerating the production of brown fat cells so people burn more calories, but this new insight could achieve the same but through enhancing the activity -- and efficiency -- of cells. &amp;quot;We are stopping the brakes within the fat cells,&amp;quot; says Vidal-Puig, as the mice in his study became protected from obesity with increased browning of their white fat cells. 

The team believe controlling energy storage will be a better approach to beat the obesity epidemic than controlling people's eating habits.

But Sztalryd warns that additional studies are required to evaluate any clinical relevance,&amp;quot;New therapies are urgently needed for obesity. sLR11 seems promising but more work is needed to confirm if this is a relevant,&amp;quot; she says.

In the mean time, old tactics may be the answer and the more weight gained, the more exercise to be done.</gtr:impact><gtr:outcomeId>56d2c22d914d30.31386052</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://edition.cnn.com/2016/02/01/health/new-protein-fat-burn-feat/</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>URJC Summer University Programme: Obesity, Insulin Resistance, and Metabolic Syndrome.</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>3FF05465-DFCB-4D63-B98C-B5283BFF4824</gtr:id><gtr:impact>5. Madrid, Spain. 9th-11th July 2015. URJC Summer University Programme: Obesity, Insulin Resistance, and Metabolic Syndrome. 


Obesity, insulin resistance, diabetes and metabolic syndrome (C&amp;oacute;digo UV-S-OBESI) 

La inscripci&amp;oacute;n ha finalizado.





Ap&amp;uacute;ntate




 
Del 09-07-2015 al 11-07-2015
 
Sal&amp;oacute;n de Grados, Campus de Madrid, Facultad de Ciencias Jur&amp;iacute;dicas y Sociales, Paseo de los Artilleros s/n 
 
 
Organizado por Vicerrectorado de Extensi&amp;oacute;n Universitaria 
 
Tel&amp;eacute;fono de contacto: 914884762 
 Categor&amp;iacute;as:
Formaci&amp;oacute;n y docencia sanitaria

Investigaci&amp;oacute;n m&amp;eacute;dica

Medicina general
Palabras clave:
Diabetes and metabolic syndrom...

Insulin resistance

Obesity</gtr:impact><gtr:outcomeId>56d1fe868a52b6.92005308</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:url>http://uverano.urjc.es/event_detail/2355/programme/obesity-insulin-resistance-diabetes-and-metabolic-syndrome-codigo-uv-s-obesi.html</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description> Wroclaw, Poland. 3rd - 7th May 2014. European Congress of Endocrinology.</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>5CE415AD-7D99-4A09-B860-E930486168EE</gtr:id><gtr:impact>Here you will find all ECE 2014 information, including details of the pre-congress courses and include the oral communications that have been chosen following the abstract selection meeting in the scientific programme.

We look forward to welcoming you to Wroclaw for ECE 2014.

Paolo Beck-Peccoz
Joint Chair, Programme Organising Committee (POC)</gtr:impact><gtr:outcomeId>56d3031729ac18.88124500</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.ece2014.org/</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Keystone Symposia</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>0466256A-F7E7-4B54-9823-F70035A94467</gtr:id><gtr:impact>Keystone Symposia - Nuclear Receptors and Friends: Roles in Energy Homeostasis and Metabolic Dysfunction. Alpbach, Austria, 3rd-8th April 2113.

 Keystone Symposia - Systems Biologyof Lipid Metabolism (9th - 13th February 2015)
Colorado, USAOrganisers: Matej Ore?ic, Antonio Vidal-Puig, Ana Maria Cuervo

Increased applicants to the lab</gtr:impact><gtr:outcomeId>Be14rP8cAoC</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>keynote/invited speaker</gtr:presentationType><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.keystonesymposia.org/index.cfm?e=web.Meeting.Program&amp;meetingid=1235</gtr:url><gtr:year>2013,2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description> 5th - 9th June 2015. ADA Scientific Sessions Insulin Action/Molecular Metabolism.</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>CA45198D-8BA8-4E36-BD6A-CBBD52FAB3A7</gtr:id><gtr:impact>Lecture American Diabetes Association Conference 2015</gtr:impact><gtr:outcomeId>56d20235b047f1.81445764</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://professional2.diabetes.org/Presentations_Details.aspx?typ=10&amp;sr=adv&amp;cgr=238&amp;congress=238</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Stockholm, Sweden. 28th June - 2nd July 2014. International Society for the Study of Fatty Acids and Lipids.</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>FAD80932-E2A6-4F7C-B199-7FD906981108</gtr:id><gtr:impact>http://www.issfal.org/conferences/2014-stockholm
Stockholm, Sweden. 28th June - 2nd July 2014. International Society for the Study of Fatty Acids and Lipids.
International conference focused on the role of fatty acids in disease</gtr:impact><gtr:outcomeId>56d2db99167b18.19295745</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.issfal.org/conferences/2014-stockholm</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description> EAS Advanced Course in Cardiometabolic Phenotyping in Rodents.</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>160E875E-EB1C-4797-9114-273FF09ED704</gtr:id><gtr:impact>EAS Advanced in Cardiometabolic Phenotyping in Rodents, Cambridge, UK

Scientists from the University of Cambridge Biomedical Campus recently hosted the 2nd EAS Advanced Course in Cardiometabolic Phenotyping in Rodents. This 3-day course combines the state of the art facilities and expertise within the Disease Model Core at the WellcomeTrust-MRC Institute of Metabolic Science and the BHF Cardiovascular Centre. By integrating the expertise of these two specialized phenotyping centres, it provides a unique opportunity to learn about many of the skills required for in depth cardiometabolic phenotyping in small animals. 

The 32 participants, selected from centres across Europe, were treated to a programme of lectures, phenotyping demonstrations and data analysis sessions. A further 1-day workshop at the Sanger/EBI focused on mouse genetics, genetic engineering and informatics resources, highlighting the great opportunities provided by recent advances in genetic engineering purpose-made mouse models. Participants particularly appreciated the mixture of hands-on experience, combined with opportunities to ask detailed questions on how the techniques demonstrated should be used to suit their own research priorities.

The course was sponsored by the European Atherosclerosis Society, British Heart Foundation and TSE systems, with organisation led by Prof Toni Vidal-Puig, Director of the MRC Metabolic Diseases Unit Disease Model Core.</gtr:impact><gtr:outcomeId>56d201a73b4213.24621581</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://tvp.mrl.ims.cam.ac.uk/events/</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Malaga, Spain. 19th - 21st October 2016. Congress of the Spanish Society of Endocrinology</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>1AF54325-4DFE-468C-BC0E-E0E49E3A21D6</gtr:id><gtr:impact>Malaga, Spain. 19th - 21st October 2016. Congress of the Spanish Society of Endocrinology</gtr:impact><gtr:outcomeId>58b98398b08817.10851895</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Engordar La ciencia Asturias</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>AF7739C2-BD73-476D-94D3-AD31E87D027C</gtr:id><gtr:impact>Engordar la ciencia
El endocrino Antonio Vidal-Puig reivindica el valor econ&amp;oacute;mico de la investigaci&amp;oacute;n al recibir el premio del Colegio de M&amp;eacute;dicos
El endocrin&amp;oacute;logo Antonio Vidal-Puig, catedr&amp;aacute;tico de la Universidad de Cambridge y uno de los mayores expertos del mundo en obesidad, aprovech&amp;oacute; la conferencia con la que recibi&amp;oacute; ayer en Oviedo el Premio Internacional Hip&amp;oacute;crates Central Lechera Asturiana de la Real Academia de Medicina y Cirug&amp;iacute;a para reclamar un mayor apoyo a la actividad investigadora en Espa&amp;ntilde;a. &amp;quot;Los pa&amp;iacute;ses que no tienen grandes recursos naturales dependen de la econom&amp;iacute;a del conocimiento, y nosotros podemos ser econ&amp;oacute;micamente m&amp;aacute;s potentes gracias a la ciencia&amp;quot;, subray&amp;oacute; Vidal-Puig, que pertenece a 21 comit&amp;eacute;s internacionales de expertos y ha publicado 220 art&amp;iacute;culos en revistas especializadas</gtr:impact><gtr:outcomeId>56d2c70ce57666.92725084</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.lne.es/asturias/2015/11/27/engordar-ciencia/1847307.html</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Suzhou, China. 1st - 5th June 2015. Cold Spring Harbor Asia (CSHA) Conference on Lipid Metabolism and Metabolic Disorders</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>A8031171-4193-4532-BBEB-6136F69A11D3</gtr:id><gtr:impact>The conference will include eight oral sessions and one poster session covering the latest findings across many topics in lipid metabolic. Many talks will be selected from the openly submitted abstracts on the basis of scientific merit and relevance. Social events throughout the conference provide ample opportunity for informal interactions.

 Alterations in lipid homeostasis play critical roles in the development of human metabolic disorders, such as obesity, type II diabetes and fatty liver. This meeting brings together world-leading experts to present and discuss latest developments in the study of lipid metabolism, as well as their implications for human health and disease. The conference will include eight oral sessions and one poster session. Additional oral presentations will be selected from the openly submitted abstracts on the basis of scientific merit and relevance. Social events throughout the conference will provide ample opportunities for scientific as well as informal interactions</gtr:impact><gtr:outcomeId>56d204766e9e13.05546558</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>https://www.csh-asia.org/2015meetings/Metabo.html</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Members of the TVP lab recently attended the 1st ICAN conference series in Cardiometabolic Disease in Paris.</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>9EF0D835-F19D-4E37-B395-A9A0963AC6EA</gtr:id><gtr:impact>TVP Lab members give presentations and posters at 1st ICAN conference series in Cardiometabolic Disease

Members of the TVP lab recently attended the 1st ICAN conference series in Cardiometabolic Disease in Paris. Vanessa Pellegrinelli was selected to give a presentation, and Camilla Ingvorsen, Guillaume Bidault, and Vivian Peirce were selected to present posters. Vivian Peirce was a joint-winner of Young Investigator poster award.



Projection of our lab</gtr:impact><gtr:outcomeId>5455123f7d4751.15222608</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.tvp.mrl.ims.cam.ac.uk/events/</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description> Alabama, USA. 19th November 2013. University of Alabama at Birmingham, Nutrition Obesity Research Center - NORC's Noon Seminar Series.</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>6160F40B-9090-4908-9548-09075C07E6E6</gtr:id><gtr:impact>The seminar is sponsored by the Nutrition Obesity Research Center and co-sponsored by the Department of Nutrition Sciences.
Addressed the problem of adipose tissue expandability and metabolic syndrome</gtr:impact><gtr:outcomeId>56d3058e776c31.55450586</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.norc.uab.edu/courses/seminars/seminar2013#</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Barcelona, Spain. 8th October 2016. CIBERDEM-MSD Symposium</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>F163C8F0-22DF-47C3-BA57-F6BE48AC93AE</gtr:id><gtr:impact>Barcelona, Spain. 8th October 2016. CIBERDEM-MSD Symposium</gtr:impact><gtr:outcomeId>58b983f02aed86.25470178</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Blog</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>A78E0043-1137-4F9C-AC5D-C863C7EF4D22</gtr:id><gtr:impact>Blog from Sanger wich bord reach where we presented our research on brown fat

From clinical studies and animal models, scientists have noticed that some obese individuals can maintain a remarkable capacity to store fat before experiencing adverse metabolic effects associated with obesity, such as insulin resistance and Type 2 diabetes. It seems that the adipose tissue of these people has developed adaptive mechanisms that allow it to preserve its functionality while adjusting its biochemical features to maintain its biophysical characteristics. Read more here.

 Blog by</gtr:impact><gtr:outcomeId>54551178adc754.68257565</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.tvp.mrl.ims.cam.ac.uk/events</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>TECHTIMES</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>126D8A14-9ECB-4E69-A9F4-AE820325A78A</gtr:id><gtr:impact>Being Fat Makes It Harder To Lose Weight: Fatter People Produce More Protein That Inhibits Depletion Of Fat Cells
Fat people have a more difficult time of losing weight because of the increased production of a protein called sLR11. This inhibits the body's ability to burn calories and fats for heat production</gtr:impact><gtr:outcomeId>56d2c5952bd1a9.82536139</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.techtimes.com/articles/110892/20151127/being-fat-makes-it-harder-to-lose-weight-fatter-people-produce-more-protein-that-inhibits-depletion-of-fat-cells.htm</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>GACETA MEDICA-Lilly</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>6033C99B-DF16-47F6-A8BA-FB17A1161590</gtr:id><gtr:impact>Gaceta M&amp;eacute;dica 
Domingo, 28 de Febrero de 2016
Felipe Casanueva Freijo, presidente de la Sociedad Espa&amp;ntilde;ola para el Estudio de la Obesidad, y Manuel Puig-Domingo, presidente de la Sociedad Espa&amp;ntilde;ola de Endocrinolog&amp;iacute;a y Nutrici&amp;oacute;n, entregaron al profesor Antonio Vidal Puig el &amp;quot;Premio Fundaci&amp;oacute;n Lilly a una Carrera Distinguida 2015&amp;quot; en la especialidad de Endocrinolog&amp;iacute;a, Nutrici&amp;oacute;n y Obesidad por su contribuci&amp;oacute;n al conocimiento del tejido adiposo y el abordaje y prevenci&amp;oacute;n de la obesidad. Este galard&amp;oacute;n fue otorgado en el marco del Simposio Internacional 'Lo &amp;uacute;ltimo en Obesidad'</gtr:impact><gtr:outcomeId>56d2ca9f6e8ed2.16484454</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.gacetamedica.com/noticias-medicina/2015-12-04/en-10-minutos/premio-a-la-trayectoria-en-endocrinologia/pagina.aspx?idart=952960</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description> 36 Congreso Sociedad Espa?ola de Farmacolog?a.</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>ACAC2131-C9B6-4CB3-B314-FEFE430E7D60</gtr:id><gtr:impact>http://congresosef2015.com/programa-cientifico/esquema-del-programa/
12:30 - 13:30 
Sesi&amp;oacute;n Plenaria.

Moderadora: Dra. M&amp;ordf; Jes&amp;uacute;s Sanz Ferrando
Universitat de Val&amp;egrave;ncia.
Adipose tissue expandability, lipotoxicity and the metabolic syndrome.
Prof. Antonio Vidal Puig University of Cambridge. Reino Unido.</gtr:impact><gtr:outcomeId>56d1fdb11c4049.44974893</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://congresosef2015.com/programa-cientifico/esquema-del-programa/</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description> London, UK. 24th April 2015. Royal Society of Medicine Symposium. Obesity: Epidemiology, complications and management.</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>67874BC4-1095-47AC-892B-4C6BA7C7168E</gtr:id><gtr:impact>This symposium provided a multidisciplinary forum for researchers and healthcare workers to discuss the most recent advances, trends and management challenges encountered in the field of obesity.

Throughout the day, delegates explored the opportunities and challenges faced by those involved in obesity medicine, together with the solutions that have currently been adopted.

The symposium aimed at all those working in the field or with an interest in obesity medicine, vascular risk medicine, PhD students, post-doctoral researchers, and clinicians of all medical specialties including medical students, foundation and core trainees, general practitioners, physicians and surgeons.</gtr:impact><gtr:outcomeId>56d1ff619a0be9.23495772</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>https://www.rsm.ac.uk/events/events-listing/2014-2015/sections/lipids,-metabolism-vascular-risk-section/lif02-obesity-epidemiology,-complications-and-management.aspx</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>. London, UK. 11th January 2017. Seminar at the MRC Clinical Sciences Centre, Imperial College London.</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>AACB9FCE-19F2-455F-B377-96B2C5252BCE</gtr:id><gtr:impact>. London, UK. 11th January 2017. Seminar at the MRC Clinical Sciences Centre, Imperial College London.</gtr:impact><gtr:outcomeId>58b98434549387.91569087</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>International Congress on Obesity 2016</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>83C76423-D8B7-4E87-9C46-023AE22E0CA2</gtr:id><gtr:impact>Vancouver, Canada. 1st - 4th May 2016. 13th International Congress on Obesity. 250 attendes</gtr:impact><gtr:outcomeId>58b980d4c96e13.37217305</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>. Cambridge, UK. 11th April 2016. British Heart Foundation Cardiovascular Research Excellence Annual Event.</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>83D9D63B-CDE4-4E8B-B6BF-3B0719CA4CD1</gtr:id><gtr:impact>4. Cambridge, UK. 11th April 2016. British Heart Foundation Cardiovascular Research Excellence Annual Event.</gtr:impact><gtr:outcomeId>58b98346c7da56.88258600</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Undergraduate students</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>11/11/2014- www.teinteresa.es, Madrid Brown fat</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>A190991E-D4B1-43C0-8872-535ADD55DE74</gtr:id><gtr:impact>La grasa marr&amp;oacute;n, clave en la lucha contra la obesidad
1456655859 
11/11/2014- www.teinteresa.es, Madrid 

Las compa&amp;ntilde;&amp;iacute;as farmac&amp;eacute;uticas est&amp;aacute;n invirtiendo en la investigaci&amp;oacute;n para desarrollar un m&amp;eacute;todo para convertir la grasa blanca en grasa marr&amp;oacute;n.
Modificaciones de la flora bacteriana han podido ayudar a reducir la obesidad en animales, y podr&amp;iacute;a aportar soluciones a la obesidad humana</gtr:impact><gtr:outcomeId>56d2cff56a99b4.91235578</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.teinteresa.es/salud/grasa-marron-clave-lucha-obesidad_0_1246676023.html</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>London, UK. 11th March 2015. Diabetes UK for the Adipose Plenary Conference.</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>72F3A5F2-779E-432F-A30B-4D76F0F43FBF</gtr:id><gtr:impact>The Diabetes UK Professional Conference, organized by the Diabetes UK will take place from 11th March to the 13th March 2015 at the Excel London in London, United Kingdom. The conference will cover areas like basic science, clinical science, education, clinical care management, healthcare delivery and psychological care.</gtr:impact><gtr:outcomeId>56d200d3bf6546.01479053</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://10times.com/diabetes-uk-professional-conference</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Blog</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>F6603EBE-F3B4-46E2-A4F9-D7450F260A4C</gtr:id><gtr:impact>Fighting fat with fat
Obesity is one of the most important biomedical problems in our society and also one of the most frustrating to tackle. For this reason, the recent identification of functional brown fat in adult humans has made the obesity research community very excited. Read more here.

Sanger Institute Blog by Dr Stefania Carobbio

Projection of our lab</gtr:impact><gtr:outcomeId>545512fa01cf99.81543785</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:url>http://www.tvp.mrl.ims.cam.ac.uk/events/</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>newsweek thermogenesis</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>F2D355DA-ECE0-44AE-A2AC-1DCB4F5BBCE5</gtr:id><gtr:impact>http://www.newsweek.com/2015/01/30/prepare-pill-make-you-thin-301250.html

In another area of Vidal-Puig's studies lies, potentially, an amazingly simple fix. In spite of all the millions spent on diets, food and exercise, it may be that something as basic as temperature is the answer. We all have two types of fat, white and brown. White fat is inert and sits in deposits. Brown fat, which regulates babies' temperatures but is much harder to pinpoint in adults, can be activated to burn calories and generate heat.

Studies show that exposure to low temperatures may encourage white fat to behave like brown fat. So while central heating ensures we move less and burn fewer calories, it's possible that lower temperatures might increase the activity of brown fat, which will burn our calories for us.</gtr:impact><gtr:outcomeId>56d2c9a85a6fe1.53975111</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.newsweek.com/2015/01/30/prepare-pill-make-you-thin-301250.html</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description> British Atherosclerosis Society Meeting: 'Atherosclerosis: crossroads of metabolism and inflammation'.</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>03F70803-3DA5-42F1-A27D-2C0A559DD179</gtr:id><gtr:impact>British Atherosclerosis Society Meeting: 'Atherosclerosis: crossroads of metabolism and inflammation'. 
British Atherosclerosis Society Autumn Meeting 2015


Atherosclerosis: Crossroads of Metabolism and Inflammation

Meeting Report

Organisers: Joseph Boyle, Ashley Miller, Martin Bennett
Date: Thursday 10th - Friday 11th September 2015
Venue: Murray Edwards College, New Hall, University of Cambridge, Cambridge
Final Programme
Sponsors: Amgen has provided unrestricted funding to support this meeting. Amgen has had no input into the programme, selection of speakers or topics.</gtr:impact><gtr:outcomeId>56d1fc8ae16502.86612881</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.britathsoc.org/previous-meetings/british-atherosclerosis-society-autumn-meeting-2015/</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>La obesidad est? en el cerebro&quot; Lilly Areces</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>A8DFF11F-B49D-4918-9DF6-30EB2016ACF7</gtr:id><gtr:impact>M&amp;aacute;s de 500 millones de personas en el mundo padecen obesidad. 
Un simposio organizado por la Fundaci&amp;oacute;n Ram&amp;oacute;n Areces y la Fundaci&amp;oacute;n General del CSIC analiza las &amp;uacute;ltimas investigaciones sobre este problema de salud p&amp;uacute;blica.</gtr:impact><gtr:outcomeId>56d2c8946fe106.21586510</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://hipertextual.com/2015/12/obesidad#</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Communicating related to impact of our research</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>EE5C52C6-FAEA-4B33-8A8C-195913ED0019</gtr:id><gtr:impact>News about our papers were disseminated through BBC radio, and TV ( BBC look East). Also through multiple webs and also reached internationally through links with European commision.

These media are supposed to reach out to the general public.</gtr:impact><gtr:outcomeId>oqDynYn5TWj</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2010,2011,2012,2013,2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description> 12th National Congress of the Spanish Society for the Study of Obesity.</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>4C57916C-6A58-4C1C-B5FE-8CEE800E411A</gtr:id><gtr:impact>12th National Congress of the Spanish Society for the Study of Obesity.</gtr:impact><gtr:outcomeId>56d1fbde1c5098.73229807</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>15th European Congress of Endocrinology</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>9D3F1D97-D55D-4E92-8EC1-91CA25A577C3</gtr:id><gtr:impact>15th European Congress of Endocrinology, Copenhagen, Denmark. 27th April - 1st May 2013.

As organiser of the conference we contributed to the impact on 3000 attendees.</gtr:impact><gtr:outcomeId>gbCB3QutbrT</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>keynote/invited speaker</gtr:presentationType><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:url>http://www.ece2013.org/</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Advisory Board Meeting</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>A600B8F9-81B7-46FD-A765-57FB53460A2D</gtr:id><gtr:impact>EASO Scientific Advisory Board Meeting 
18th - 19th March 2013, Brussels


redefinitionn of obesity on the baseis of body composition. BMI considered obsolete.</gtr:impact><gtr:outcomeId>KQ52cyyADXd</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>SCIENCEALERT ON LR11</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>397BA2AD-14A7-472D-AB57-E18EAD7A4534</gtr:id><gtr:impact>Scientists have figured out how your body fights your attempts to lose weight 
Bummer.
DAVID NIELD 
11 DEC 2015 
For those of you who feel like your gym sessions aren't getting you anywhere near your target weight - scientists think they might have found a reason why. A new study has identified a protein that locks excess fat in our bodies, preventing it from being burned off easily. 

And while it sucks to know that our bodies are fighting against our attempts to lose weight, the discovery could help to explain why overweight people find it so difficult to shed the additional pounds.</gtr:impact><gtr:outcomeId>56d2c42aa78465.66143404</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.sciencealert.com/here-s-how-your-body-naturally-fights-your-attempts-to-lose-weight</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>3. Tsukuba, Japan. 17th-19th September 2016. Tsukuba Global Science Week.</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>2F4AE567-634B-4835-8BED-A16133688B5C</gtr:id><gtr:impact>Tsukuba, Japan. 17th-19th September 2016. Tsukuba Global Science Week.</gtr:impact><gtr:outcomeId>58b981f751d4a8.64003747</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Blog</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>C6C5242C-3B89-4106-9502-523AE2EA6CAF</gtr:id><gtr:impact>Blog from Sanger wich bord reach where we presented our research on brown fat

From clinical studies and animal models, scientists have noticed that some obese individuals can maintain a remarkable capacity to store fat before experiencing adverse metabolic effects associated with obesity, such as insulin resistance and Type 2 diabetes. It seems that the adipose tissue of these people has developed adaptive mechanisms that allow it to preserve its functionality while adjusting its biochemical features to maintain its biophysical characteristics. Read more here.

 Blog by</gtr:impact><gtr:outcomeId>5455116d840832.39891014</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.tvp.mrl.ims.cam.ac.uk</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Turku, Finland. 28th January 2016. Frontiers of Science Seminar Series at Biocity Turku</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>43A09D35-4A89-4910-80D9-3FDB8B284284</gtr:id><gtr:impact>http://www.biocity.turku.fi/index.php?id=858
Thursday, January 28
Prof. Antonio Vidal-Puig, University of Cambridge, MRC Institute of Metabolic Science, Cambridge, UK
&amp;quot;Adipose tissue expandability, lipotoxicity and the metabolic syndrome&amp;quot;
Host: Matej Oresic (mtjo(at)steno.dk)</gtr:impact><gtr:outcomeId>56d308c5836148.28529677</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.biocity.turku.fi/index.php?id=858</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Adipose tissue expandaqbility-EL COMERCIO ASTURIAS</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>950F3C9D-C1A3-4D74-98DC-1D09066BC0C8</gtr:id><gtr:impact>&amp;lt;&amp;gt;
Antonio Vidal-Puig, catedr&amp;aacute;tico en Cambridge y director adjunto del Centro de Obesidad y Enfermedades Asociadas. Premio Internacional Hip&amp;oacute;crates 2015
&amp;lt;&amp;gt;</gtr:impact><gtr:outcomeId>56d2cbc1d79f77.95470925</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.elcomercio.es/asturias/201511/27/puede-obeso-saludable-siempre-20151127002423-v.html</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description> Colorado, USA. 9th - 13th February 2015. Keystone Symposia - Systems Biology of Lipid Metabolism.</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>C3B64532-9DFD-4CC7-A83E-6D69D5823336</gtr:id><gtr:impact>Keystone Symposia organiser and speaker. 
Area Lipid Biochemistry</gtr:impact><gtr:outcomeId>56d202d312f7d6.10933276</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.keystonesymposia.org/15B4</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>LR11 in Asia</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>019F13FE-B166-4393-83BE-CB6B00A155FF</gtr:id><gtr:impact>LR11 news disseminated in Asia
???LR11/SorLA?????????????????????BMI???????????
Soluble LR11/SorLA represses thermogenesis in adipose tissue and correlates with BMI in humans</gtr:impact><gtr:outcomeId>56d2ccf3d68ff7.04439773</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>https://www.natureasia.com/ja-jp/ncomms/abstracts/71218</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Cherry Hinton Lions Under 10s Blue Football Club sponsored by IMS/TVP lab</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>ED146B6C-8301-4F61-A8CD-A50B8EC84401</gtr:id><gtr:impact>This is an action to promote fitness in children as a strategy to prevent orreverse obesity

Children know what is the IMS and that obesity and diabetes can be prevented by exercise.</gtr:impact><gtr:outcomeId>545513c0e79805.83475302</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:url>http://www.tvp.mrl.ims.cam.ac.uk/events/</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Cambridge, UK. 13th April 2015. BHF Centre of Research Annual Symposium.</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>0D3AD859-4511-409D-B407-801333A4E0E8</gtr:id><gtr:impact>http://www.cardiovascular.cam.ac.uk/
The overarching scientific objective of the Centre is to advance understanding of pathobiology, diagnosis, prevention and therapy of selected common and rare cardiovascular conditions by applying our combined expertise in generating assumption-free approaches.</gtr:impact><gtr:outcomeId>56d20038d021b1.31686599</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.cardiovascular.cam.ac.uk/research/cambridgecre</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Europe press</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>5032C723-773F-4D65-BEA4-0DBFD77953A1</gtr:id><gtr:impact>This was an interview for Europe press news agency which has a huge diseminattion capacity. Some examples below.

http://www.europapress.es/chance/noticias.aspx?buscar=Antonio%2BVidal%2BPuig

http://www.europapress.es/chance/elbuenvivir/noticia-10-obesos-son-saludables-20111128124545.html

http://www.europapress.es/chance/noticias.aspx?buscar=Cambridge

http://www.enfermeriapalencia.com/modules.php?name=Noticias_enfermeras

Highewr visibility. Partients have contacted me through email with personal cases that have I have replayed so far but that if they continue to increase i may need to organise better through my web page. I am considering if i get resources to maintain in to include a page in my web for public questions and disemination.</gtr:impact><gtr:outcomeId>hrRKLJB14p6</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:url>http://www.europapress.es/chance/noticias.aspx?buscar=Antonio%2BVidal%2BPuig</gtr:url><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Blog</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>DD8A0B14-ECD6-47C4-B899-62D35114DC0B</gtr:id><gtr:impact>Blog from Sanger wich bord reach where we presented our research on brown fat

From clinical studies and animal models, scientists have noticed that some obese individuals can maintain a remarkable capacity to store fat before experiencing adverse metabolic effects associated with obesity, such as insulin resistance and Type 2 diabetes. It seems that the adipose tissue of these people has developed adaptive mechanisms that allow it to preserve its functionality while adjusting its biochemical features to maintain its biophysical characteristics. Read more here.

 Blog by Dr Stefania Carobbio</gtr:impact><gtr:outcomeId>5455116a685de3.90097308</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.tvp.mrl.ims.cam.ac.uk</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>International Symposium: Latest in obesity Madrid, Spain. 1st - 2nd December 2015.</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>674710AE-41C5-4190-A3D6-C6D555E3B60A</gtr:id><gtr:impact>http://www.fundacionareces.es/fundacionareces/cargarAplicacionAgendaEventos.do?idTipoEvento=1&amp;amp;identificador=1827?elAgenda=2
Along with obesity, diabetes is a true pandemic of the 21st century which carries a certain risk of other diseases such as cardiovascular diseases, or even cancer. It is purpose of this symposium to bring to our attention and knowledge the most recent advances on the disease and we hope to do so thanks to the remarkable roster of personalities who have accepted our invitation to share their knowledge and ideas in this INTERNATIONAL SCIENTIFIC SYMPOSIUM: LATEST IN OBESITY sponsored by the Fundaci&amp;oacute;n Ram&amp;oacute;n Areces and with the collaboration of the Fundaci&amp;oacute;n General CSIC.</gtr:impact><gtr:outcomeId>56d1fae2625e02.76678003</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.fundacionareces.es/fundacionareces/cargarAplicacionAgendaEventos.do?idTipoEvento=1&amp;identificador=1827&amp;nivelAgenda=2</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Heidelberg, Germany. 16th - 17th October 2015. International Symposium On Diabetic Complications</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>AA07A109-019F-4608-97F5-09A9883F7DBD</gtr:id><gtr:impact>Heidelberg, Germany. 16th - 17th October 2015. International Symposium On Diabetic Complications
Event Description

HIDC 2015, 2th Heidelberg International Symposium on Diabetic Complications is going to be placed in between 16 October, 2015 and 17 October, 2015. 

The Symposium place is going to be Heidelberg University Hospital. 

HIDC 2015 is likely to be a stage where many notable themes are likely to be discoursed. Several of these are going to be Biology, Metabolic Diseases, Diabetes, Diabetes Research, Medical and Health Care. 

2th Heidelberg International Symposium on Diabetic Complications is organized annually.</gtr:impact><gtr:outcomeId>56d203f1585c30.18883374</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>https://www.klinikum.uni-heidelberg.de/Welcome.138789.0.html</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Blog BAT</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>AE391485-629B-4118-89C8-B375E2B29D83</gtr:id><gtr:impact>Blog from Sanger wich bord reach where we presented our research on brown fat

From clinical studies and animal models, scientists have noticed that some obese individuals can maintain a remarkable capacity to store fat before experiencing adverse metabolic effects associated with obesity, such as insulin resistance and Type 2 diabetes. It seems that the adipose tissue of these people has developed adaptive mechanisms that allow it to preserve its functionality while adjusting its biochemical features to maintain its biophysical characteristics. Read more here.

 Blog by</gtr:impact><gtr:outcomeId>5455117e311dc1.11948341</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.tvp.mrl.ims.cam.ac.uk/events</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Antalya, Turkey. 23rd-26th October 2014. Endobridge.</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>C15FC369-3D3C-4530-AE75-B0124EE71B64</gtr:id><gtr:impact>ENDOBRIDGE 2014, 2nd EndoBridge Meeting is one of the extensive event on Pituitary Disease, Thyroid Disorders, Obesity, Endocrinology, Endocrine, Medical, Hormone Research, Hormonal Systems, Ageing, Bone And Osteoporosis, Diabetes, Hormones, Paediatric Endocrinology, Puberty, Steroids and Testosterone segments. 
2nd EndoBridge Meeting is organized annually.</gtr:impact><gtr:outcomeId>56d2bfc71d24b3.12466745</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://eventegg.com/endobridge-2014/</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>350000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:department>Horizon 2020</gtr:department><gtr:description>2020 Horizon Epoos</gtr:description><gtr:end>2017-09-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>E153C7FD-BC97-4ACC-9611-F65A5F72D7CB</gtr:id><gtr:outcomeId>56d1f5d988e428.90878329</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2013-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>300000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:department>Seventh Framework Programme (FP7)</gtr:department><gtr:description>FP7 - IMI EMIF Joint Undertaking. PI: Dr Vidal-Puig. &amp;pound;300,000.</gtr:description><gtr:end>2016-12-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>C9EE8FDB-28E4-4DF7-AC65-EA3350584F87</gtr:id><gtr:outcomeId>5454f3543a8d57.34330615</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2014-12-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>The purpose of this study was to determine the role, if any, of fatty acid elongation in brown adipose tissue function. To that end we utilised the elovl6 KO mouse as a model with altered fatty acid elongation. Elovl6 was well suited to this roll, as it is expressed at much higher levels in brown adipose tissue than any other tissue. Elovl6 is regulated by thermogenic challenges and is upregulated by cold exposure and reduced by thermoneutral housing. Unlike previous studies of elongation and its roll in BAT function by studying Elovl3, Elovl6 do not have an obvious skin barrier defect, removing the confounding factor of poor thermal insulation on studies of BAT function. 



In line with the concept that Elovl6 was important for brown adipose tissue function we have identified that Elovl6 KO mice have a temperature dependent post natal survival. At 20oC, as reported previously, only 30% of Elovl6 KO pups survive to 3 weeks of age. However, this is not embryonic lethality as reported but instead is a temperature dependent post-natal lethality. The mendelian ratios of elovl6 KO mice can be corrected by breeding and housing pups at 24oC until weaning. This phenotype is reminiscent of other mouse models with defective BAT activity (UCP1 and PACAP). In adulthood, when housed at 24oC, mice lacking Elovl6 have a normal energy balance phenotype, with no differences in energy expenditure or food intake. However, Elovl6 was upregulated by cold exposure. In order to investigate this phenotype more fully we cold exposed Elovl6 KO mice. Mice lacking elovl6 exhibited both elevated energy expenditure and food intake (hypermetabolism). The mechanism behind this hypermetabolism remains to be elucidated but it is notable that the Elovl6 mice at both 24oC and 4oC exhibit increased expression of thermogenic markers in subcutaneous white adipose tissue (the location of so called beige adipocytes or 'Brite' cells) and to a lesser extent in canonical brown fat. 



Elovl6 KO mice have shorter chain fatty acids compared to WT mice. In WT mice, cold exposure leads to significant changes in fatty acid chain length in brown adipose, white adipose and liver tissue, but not in muscle. It is possible it is a direct regulatory event in which loss of Elovl6 results in an increased thermogenic response to cold via central mechanisms. However, a second possibility is that loss of Elovl6 has actually resulted in partially defective BAT. While this would seem paradoxical the UCP1 KO mouse exhibits elevated energy at sub thermoneutral temperatures, with the biggest discrepancy between WT and UCP1 KO mice being at 4oC - the lowest temperature studied. In mice, cold exposure has been demonstrated to dramatically increase levels of stearate in brown adipose tissue mitochondria, but not in muscle mitochondria, suggesting that altered mitochondrial function may contribute to the hypermetabolic phenotype. This aspect is currently under investigation. 



Finally, in addition to our specific investigations into the Elovl6 model we have carried out an extensive characterisation of adipose tissue lipid changes in various dietary and genetic models of obesity. So far, this has demonstrated that obesity and insulin resistance are associated with a lipid profile consistent with elevated SCD1 and Elovl6 activity, even after the composition of diets has been taken into account. This finding is consistent with the improved metabolic profiles of SCD1 (liver specific) and Elovl6 KO (whole organism) mouse models.</gtr:description><gtr:exploitationPathways>Our research has potentially important implications for the functional food industry. In particular margarines and yoghurt drinks have been an area of intense focus of research and marketing by many of the major players in the FMCG world (Unilever's Flora Pro Active and Raiso group's Benecol are the leading brands in the UK with combined sales exceeding 50 million GBP). While these products have focused on cholesterol lowering, there remains a large area to exploit in the area of functional foods with modified lipid compositions and improved metabolic outcomes. Making functional food claims is increasingly difficult following EU regulations, requiring greater scientific evidence. By providing a scientific basis to support the roles of specific lipids in animal and fly models will allow a more rational and targeted design for the development of new lipid-modifying functional foods.



Whether Elongase 6 is a valid target for pharmacological agents is at present difficult to assess. Whole organism ablation of Elovl6 in mice improves insulin sensitivity, but while the mechanism remains unclear it is difficult to assess the likelihood of its efficacy and safety in humans. 
 The research funded by this grant will provide substantial benefit to the research community working in both metabolic science and lipid biology. By identifying unique roles for the products of Elovl6 in control of energy balance and brown adipose tissue function will enable a better understanding of the impact of modified diets and a deeper understanding of what lipid changes mean. 



At present lipidomics is limited by a lack of functional information for many lipid species and on going work to improve this area of our understanding of metabolism is vital. The research related to the role of Elovl6 in regulating mitochondrial function will be invaluable to almost all areas of biology in which mitochondrial function is important. The alteration in fatty acid chain length in mouse models of obesity suggests a wider role of the elongases in the development of obesity related metabolic complications, this can potentially be targeted through dietary or pharmacological manipulation.</gtr:exploitationPathways><gtr:id>4B92930D-85A2-42C0-BFC0-C8BFE44F2470</gtr:id><gtr:outcomeId>r-4506757133.180981774b4800</gtr:outcomeId><gtr:sectors><gtr:sector>Healthcare,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:sectors></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Editorial Activity</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>75200065-BB0D-4140-ABF3-0F538344AEBD</gtr:id><gtr:impact>? Editorial Advisory Board: PLoS Biol (2009-)
? Editorial Board Memberships: PLoS Biology (2007-), Biochemical Journal (2008-2012), Diabetes (2012-) Trends Endocrinology and Metabolism (2008-), Biochim Biophys Acta.(2012-).Guest Editor (with RH Unger) of Special issue on lipotoxicity. Biochim Biophys Acta. 2010 Mar;1801(3):207-8.</gtr:impact><gtr:outcomeId>56d2d3716e3687.75325138</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Organisation of conferences/Courses</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>E4D658E4-3118-4D21-8CF2-1F02FB161F82</gtr:id><gtr:impact>It is expected these training schemes have contributed to better care and scientifc developments.

Member of the Scientific Organising Committee

1. Cambridge, United Kingdom. 30th June - 2nd July 2015. EAS Advanced Course in Cardiometabolic Phenotyping in Rodents.
2. Boston, USA. 5th - 9th June 2015. ADA Scientific Sessions Insulin Action/Molecular Metabolism.
3. Colorado, USA. 9th - 13th February 2015. Keystone Symposia - Systems Biology of Lipid Metabolism. 
4. Madrid, Spain. 7th - 8th November 2014. CNIC Conference &amp;quot;Energy homeostasis and metabolic disease&amp;quot;. 
5. Madrid, Spain. 7th-8th November 2014. Energy homeostasis and metabolic disease. CNIC.
6. Cambridge, UK. 30th September 2014. 14th Annual Cambridge Immunology Forum Meeting. 


? Member of the Scientific Organising Committee Keystone meeting on Nuclear receptors. (http://www.keystonesymposia.org/Meetings/viewMeetings.cfm?MeetingID=1235?Tab=travel) Austria (2013)
? Member of the Scientific Organising Committee 15th European Congress of Endocrinology 27th April - 1st May 2013. Copenhagen, Denmark (http://www.ece2013.org/committees.aspx)
? Director of The European Atherosclerosis Society Advanced Course IV: Murine Genetics and Cardiometabolic Phenotyping 11th - 14th July 2012. Cambridge, United Kingdom (http://www.eas-society.org/advanced-course-iv,-cambridge.aspx
? Member of the Organising Scientific Committee of The Royal Society and Academy of Medical Sciences symposium on &amp;quot;Brown adipose tissue: a new human organ?&amp;quot; London (2012) (http://www.physoc.org/me2012) 
? Member of the Organising Scientific Committee The Obese Species Workshop Sicily, Italy. 21st - 26th October (2011) http://theobesespecies.unipr.it/.
? Member of the Organising Scientific Committee for the meeting of the EAS in Hamburg. Germany (2010)
? Member of the Organising Scientific Committee of the 49th International Conference on the Bioscience of Lipids. Maastrich (2008)</gtr:impact><gtr:outcomeId>scYTFVx5j3f</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>SAB scientific Advisory boards</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>159D7279-74DB-42B6-A40E-2D7D68490D46</gtr:id><gtr:impact>Evidence of international standing

? MRC College of experts (1/10/2004-30/09/2008).
? MRC Physiological Systems and Clinical Sciences Board (1/10/2004-30/09/08).
? MRC Funding Schemes: Survey panel (2003-2004).
? International scientific advisor Spanish Research Council, Metabolism and Nutrition Node (2003-2008). 
? Member of the Editorial Board of PLoS Biology, Diabetes, Biochemical Journal and Trends Endocrinology and Metabolism.
? Member of PLoS Biology Advisory Board (2010-)
? EAS 2010 Scientific Committee
? EAS Election Committee Member
? Member of the Diabetes UK Research Committee 
? International Scientific Committee of CIBERDEM
? FP7 FLORINASH Scientific Advisory Board
? Committee for Severo Ochoa Research Excellence Awards of Spanish Ministry of Innovation.
? IDIBAPS Scientific Advisory Board (2012-)
? EASO Scientific Advisory Board (2013-)
? Member of Wellcome Trust Strategic Award [Biological determinants of ageing and late life health, and their pharmacological manipulation] Scientific Advisory Board (2013-)-)
? Scientific Advisory Board of Institut d'Investigacions Biom&amp;egrave;diques de Girona (IDIBGI) (2013-)</gtr:impact><gtr:outcomeId>56d2d2eb429677.85556376</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type><gtr:url>http://tvp.mrl.ims.cam.ac.uk/events/</gtr:url></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs><gtr:researchDatabaseAndModelOutput><gtr:description>Development of tools for lipid analysis and integration with gene expressison analysis using multivariant analysis</gtr:description><gtr:id>38CAB675-6630-44A7-B0C5-720499770458</gtr:id><gtr:impact>Fundamental for papers including lipidomic analysis which is central to our programme</gtr:impact><gtr:outcomeId>54550606a9cad1.21755612</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Technology  for lipidomic data analysis</gtr:title><gtr:type>Data analysis technique</gtr:type><gtr:yearFirstProvided>2014</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>This is a novel technology to evaluate maximal capacity of energy expenditure and is the best method to evaluate defects in energy expenditure leading to obesity.</gtr:description><gtr:id>0CECA64F-F5A8-4818-A2E3-61A3A56DD461</gtr:id><gtr:impact>Contributed to make research results reproducible and also contributes to 3R,</gtr:impact><gtr:outcomeId>58b9864f55ffe1.88888625</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Modelst for maximal termogenic capacity evaluation</gtr:title><gtr:type>Data analysis technique</gtr:type><gtr:yearFirstProvided>2015</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>This tissues and their RNA are being used for quick validation of metabolic relevance of genes identified by genomic approaches. This resourcedecreases the need of experimental groups of animals</gtr:description><gtr:id>EBC21639-4B76-4D0C-9026-E9CE1CB19542</gtr:id><gtr:impact>identification of interesting candidate genes for metabolic disease prioritising murine work

1. Yew Tan C, Virtue S, Murfitt S, Robert LD, Phua YH, Dale M, Griffin JL, Tinahones F, Scherer PE, Vidal-Puig A. Adipose tissue fatty acid chain length and mono-unsaturation increases with obesity and insulin resistance. Sci Rep. 2015 Dec 17;5:18366. doi: 10.1038/srep18366.

2. Tan CY, Virtue S, Bidault G, Dale M, Hagen R, Griffin JL, Vidal-Puig A. Brown Adipose Tissue Thermogenic Capacity Is Regulated by Elovl6. Cell Rep. 2015 Dec 15;13(10):2039-47. doi: 10.1016/j.celrep.2015.11.004. Epub 2015 Nov 25.

3. Lee EY, Sakurai K, Zhang X, Toda C, Tanaka T, Jiang M, Shirasawa T, Tachibana K, Yokote K, Vidal-Puig A, Minokoshi Y, Miki T. Unsuppressed lipolysis in adipocytes is linked with enhanced gluconeogenesis and altered bile acid physiology in Insr(P1195L/+) mice fed high-fat-diet. Sci Rep. 2015 Nov 30;5:17565. doi: 10.1038/srep17565.

4. Whittle AJ, Jiang M, Peirce V, Relat J, Virtue S, Ebinuma H, Fukamachi I, Yamaguchi T, Takahashi M, Murano T, Tatsuno I, Takeuchi M, Nakaseko C, Jin W, Jin Z, Campbell M, Schneider WJ, Vidal-Puig A*, Bujo H*. Soluble LR11/SorLA represses thermogenesis in adipose tissue and correlates with BMI in humans. Nat Commun. 2015 Nov 20;6:8951. doi: 10.1038/ncomms9951.* Corresponding Author

5. Schreiber R, Hofer P, Taschler U, Voshol PJ, Rechberger GN, Kotzbeck P, Jaeger D, Preiss-Landl K, Lord CC, Brown JM, Haemmerle G, Zimmermann R, Vidal-Puig A, Zechner R Hypophagia and metabolic adaptations in mice with defective ATGL-mediated lipolysis cause resistance to HFD-induced obesity. Proc Natl Acad Sci U S A. 2015 Nov 10;112(45):13850-5. doi: 10.1073/pnas.1516004112. Epub 2015 Oct 27

6. Senyilmaz D, Virtue S, Xu X, Tan CY, Griffin JL, Miller AK, Vidal-Puig A, Teleman AA. Regulation of mitochondrial morphology and function by stearoylation of TFR1. Nature. 2015 Jul 27. doi: 10.1038/nature14601.

7. Moreno-Navarrete JM, Escot&amp;eacute; X, Ortega F, Camps M, Ricart W, Zorzano A, Vendrell J, Vidal-Puig A, Fern&amp;aacute;ndez-Real JM. Lipopolysaccharide binding protein is an adipokine involved in the resilience of the mouse adipocyte to inflammation. Diabetologia. 2015 Jul 23.</gtr:impact><gtr:outcomeId>54550540725f42.20646932</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Tissue bank from mice undergoing physiological challenges and specific genetic modifications</gtr:title><gtr:type>Database/Collection of data</gtr:type><gtr:yearFirstProvided>2013</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput></gtr:researchDatabaseAndModelOutputs><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>A more accurate and refined methodology to assess tissue specific insulin resistance</gtr:description><gtr:id>5E49CFD7-E1E9-4267-8086-8D4733F2867E</gtr:id><gtr:impact>Schreiber R, Hofer P, Taschler U, Voshol PJ, Rechberger GN, Kotzbeck P, Jaeger D, Preiss-Landl K, Lord CC, Brown JM, Haemmerle G, Zimmermann R, Vidal-Puig A, Zechner R.
Hypophagia and metabolic adaptations in mice with defective ATGL-mediated lipolysis cause resistance to HFD-induced obesity.
Proc Natl Acad Sci U S A. 2015 Nov 10;112(45):13850-5. doi: 10.1073/pnas.1516004112. Epub 2015 Oct 27.
PMID: 26508640 Free PMC Article


Smith MA, Katsouri L, Irvine EE, Hankir MK, Pedroni SM, Voshol PJ, Gordon MW, Choudhury AI, Woods A, Vidal-Puig A, Carling D, Withers DJ.Ribosomal S6K1 in POMC and AgRP Neurons Regulates Glucose Homeostasis but Not Feeding Behavior in Mice.Cell Rep. 2015 Apr 21;11(3):335-43. doi: 10.1016/j.celrep.2015.03.029. Epub 2015 Apr 9.
PMID: 25865886 Free PMC Article</gtr:impact><gtr:outcomeId>56d2d6c299ff79.76596171</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Hyperinsulinaemic clamps using non stable isotopes</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type><gtr:yearFirstProvided>2015</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Protocol tomeasure maximal thermogenic capacity</gtr:description><gtr:id>003D3D03-B65C-4CA4-9B31-AE0ABB5BF158</gtr:id><gtr:impact>Contribution to increase accuracy of murine sudies allowing refinment, and reduction of animals</gtr:impact><gtr:outcomeId>545502c0a83511.05828747</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Phenotyping of mice; Maximal thermogenic activity</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type><gtr:yearFirstProvided>2013</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>This is a new cageingsystem for metabolicphenotyping for simultaneous assessment of food inatke, energy expnditure, activity, water consumption. The equipment incorporates novel features such as having food delivery system hook to the cover of the cage. Also this is system is adapted to the cages where are normally hold which prevents measurement artifacts derived from changes in the cages when performing metabolic measurements. The new developed system to assess energy balance is a refinement because we can measure more accurately in each experiment. The addition of a 24h camera system with Visual Sonics software enables us to have secure systems to observe without disturbing measurements.</gtr:description><gtr:id>3D093B05-4B05-4066-BF58-306F5E2E4707</gtr:id><gtr:impact>Reduction and refinement of experiments using murine models</gtr:impact><gtr:outcomeId>jpW8yAxq5Wq</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>b)	Design a unique in house system for energy balance measurement.</gtr:title><gtr:type>Physiological assessment or outcome measure</gtr:type><gtr:yearFirstProvided>2010</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Development of three core facilities, a) Murine phenotyping, b) Murine Biochemistry and c) Murine Histopathology</gtr:description><gtr:id>A34D5981-4C23-45BE-BBD2-0D75D8960316</gtr:id><gtr:impact>Development of MRC CORD murine metabolic programme
Development and expansion vreating the Cambridge Phenomics centre.</gtr:impact><gtr:outcomeId>D218E862BCE</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Development of the Phenomics center</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type><gtr:yearFirstProvided>2006</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Refined technology to measure lipid composition.</gtr:description><gtr:id>DAB0CAB2-8173-4EF9-9958-6DD58F60D4AE</gtr:id><gtr:impact>1. Yew Tan C, Virtue S, Murfitt S, Robert LD, Phua YH, Dale M, Griffin JL, Tinahones F, Scherer PE, Vidal-Puig A. Adipose tissue fatty acid chain length and mono-unsaturation increases with obesity and insulin resistance. Sci Rep. 2015 Dec 17;5:18366. doi: 10.1038/srep18366.

2. Tan CY, Virtue S, Bidault G, Dale M, Hagen R, Griffin JL, Vidal-Puig A. Brown Adipose Tissue Thermogenic Capacity Is Regulated by Elovl6. Cell Rep. 2015 Dec 15;13(10):2039-47. doi: 10.1016/j.celrep.2015.11.004. Epub 2015 Nov 25.

3. Senyilmaz D, Virtue S, Xu X, Tan CY, Griffin JL, Miller AK, Vidal-Puig A, Teleman AA. Regulation of mitochondrial morphology and function by stearoylation of TFR1. Nature. 2015 Jul 27. doi: 10.1038/nature14601.</gtr:impact><gtr:outcomeId>56d2d75a191f68.55613644</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Mass Spectrometry to analyse lipids</gtr:title><gtr:type>Model of mechanisms or symptoms - in vitro</gtr:type><gtr:yearFirstProvided>2015</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>LEM-PCR: a method for determining relative transcript isoform proportions using real-time PCR without a standard curve.Virtue S, Dale M, Sethi JK, Vidal-Puig A.
Genome. 2010 Aug;53(8):637-42.</gtr:description><gtr:id>B68B2EF0-50B6-4BD1-BCC3-FB6E89F18C88</gtr:id><gtr:impact>Improved accuracy of data analysis</gtr:impact><gtr:outcomeId>qQxNc6Q64uw</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Tools for data quatification</gtr:title><gtr:type>Model of mechanisms or symptoms - in vitro</gtr:type><gtr:yearFirstProvided>2010</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Microarray and lipidomic data form in vivo experiments using animal models</gtr:description><gtr:id>38590F16-517B-45B0-963B-0632A02674BE</gtr:id><gtr:impact>This material has been utilised by other EU groups focused in modelling and development of tools for nutritional research</gtr:impact><gtr:outcomeId>8668068A9B9</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Microarray/lipidomic  data bases</gtr:title><gtr:type>Biological samples</gtr:type><gtr:yearFirstProvided>2007</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Protocols do differentiation of Human PSC to brown, white and macrophage phenotype</gtr:description><gtr:id>645F7B75-52EB-46D9-B3A1-2ACDBA7FC776</gtr:id><gtr:impact>Competitiveness in our research and funding acquisition e.g. ERC grant</gtr:impact><gtr:outcomeId>58b98562619a65.89624617</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Differentiation of ES cells</gtr:title><gtr:type>Cell line</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We have contributed to develop methods for lipid analysis</gtr:description><gtr:id>D4C4B03E-F55B-4977-B3EB-12BD2491FAFE</gtr:id><gtr:impact>1) Oresic M, H?nninen VA, Vidal-Puig A.Lipidomics: a new window to biomedical frontiers.Trends Biotechnol. 2008 Dec;26(12):647-52. Epub 2008 Oct 23PMID: 18951641 2)Tang J, Tan CY, Oresic M, Vidal-Puig A. Integrating post-genomic approaches as a strategy to advance our understanding of health and disease. Genome Med. 2009 Mar 30;1(3):35. [Epub ahead of print] PMID: 19341506 3) Yetukuri L, Ekroos K, Vidal-Puig A, Oresic M. Informatics and computational strategies for the study of lipids.Mol Biosyst. 2008 Feb;4(2):121-7. Epub 2007 Dec 18. Review. 4).Oresic M, Vidal-Puig A, H?nninen V.Metabolomic approaches to phenotype characterization and applications to complex diseases.Expert Rev Mol Diagn. 2006 Jul;6(4):575-85. Review.</gtr:impact><gtr:outcomeId>4BBCE927162</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Development of methodology for microarray and lipidomic analysis</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:url>http://europepmc.org/abstract/MED/18951641</gtr:url><gtr:yearFirstProvided>2007</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>CBF8B249-A4AB-4B2D-950C-B8F5A74CE8DE</gtr:id><gtr:title>Meal rich in carbohydrate, but not protein or fat, reveals adverse immunometabolic responses associated with obesity.</gtr:title><gtr:parentPublicationTitle>Nutrition journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/df813db47b72f32fdc1491b2b96ec495"><gtr:id>df813db47b72f32fdc1491b2b96ec495</gtr:id><gtr:otherNames>Parvaresh Rizi E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1475-2891</gtr:issn><gtr:outcomeId>58b96da9057fe4.80858977</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>095BD82F-3508-4170-B947-1689D93BDFC7</gtr:id><gtr:title>Stearoyl-CoA Desaturase 1 Is a Key Determinant of Membrane Lipid Composition in 3T3-L1 Adipocytes.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/89fbfd715cfa7a742a5e3d8de973a98c"><gtr:id>89fbfd715cfa7a742a5e3d8de973a98c</gtr:id><gtr:otherNames>Rodriguez-Cuenca S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>58b96da9911239.93255173</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EAC6FC06-BA7B-466F-856F-48667161741A</gtr:id><gtr:title>Brown Adipose Tissue Thermogenic Capacity Is Regulated by Elovl6.</gtr:title><gtr:parentPublicationTitle>Cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5b0fe1561e92f157420919eb81c6a910"><gtr:id>5b0fe1561e92f157420919eb81c6a910</gtr:id><gtr:otherNames>Tan CY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:outcomeId>56cdf4db246768.87965613</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0D94B873-70B3-4A52-ACC7-3C3030148A2E</gtr:id><gtr:title>Adipose tissue plasticity: how fat depots respond differently to pathophysiological cues.</gtr:title><gtr:parentPublicationTitle>Diabetologia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a2f6fa35b5d82a323e0c15bcb6bdef6d"><gtr:id>a2f6fa35b5d82a323e0c15bcb6bdef6d</gtr:id><gtr:otherNames>Pellegrinelli V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0012-186X</gtr:issn><gtr:outcomeId>58b96da86913f3.12801721</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2CD86AFF-5FE5-447F-B45D-FFE48E8CB08B</gtr:id><gtr:title>Lipid zonation and phospholipid remodeling in nonalcoholic fatty liver disease.</gtr:title><gtr:parentPublicationTitle>Hepatology (Baltimore, Md.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8face52ad7d0211d931dd00159b1afe3"><gtr:id>8face52ad7d0211d931dd00159b1afe3</gtr:id><gtr:otherNames>Hall Z</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0270-9139</gtr:issn><gtr:outcomeId>58b96da93d0964.82121958</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EA01AB75-77D2-4113-8333-D6A0B857226C</gtr:id><gtr:title>Prostaglandin profiling reveals a role for haematopoietic prostaglandin D synthase in adipose tissue macrophage polarisation in mice and humans.</gtr:title><gtr:parentPublicationTitle>International journal of obesity (2005)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e137cbde914442352a009c77419799ba"><gtr:id>e137cbde914442352a009c77419799ba</gtr:id><gtr:otherNames>Virtue S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0307-0565</gtr:issn><gtr:outcomeId>56cdf4dd0461b3.29863385</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E969AB47-2A0B-478E-A190-8A8213986C92</gtr:id><gtr:title>Regulation of mitochondrial morphology and function by stearoylation of TFR1.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/79ebcc3b3a811bc866b680f632d96c20"><gtr:id>79ebcc3b3a811bc866b680f632d96c20</gtr:id><gtr:otherNames>Senyilmaz D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>56cdf4dc9af208.95616123</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B63CC324-AD3B-4D20-ABAB-12A0CD8892BE</gtr:id><gtr:title>Protein CoAlation: a redox-regulated protein modification by coenzyme A in mammalian cells.</gtr:title><gtr:parentPublicationTitle>The Biochemical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/017409e614c78b536c7c65683fedc43a"><gtr:id>017409e614c78b536c7c65683fedc43a</gtr:id><gtr:otherNames>Tsuchiya Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0264-6021</gtr:issn><gtr:outcomeId>5aa422d1241983.61731612</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F58A8124-B6B7-44BD-A3F9-30B56B748AA8</gtr:id><gtr:title>Adipose Tissue Function and Expandability as Determinants of Lipotoxicity and the Metabolic Syndrome.</gtr:title><gtr:parentPublicationTitle>Advances in experimental medicine and biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f3098d46384b300a0dd4b590e33f76cd"><gtr:id>f3098d46384b300a0dd4b590e33f76cd</gtr:id><gtr:otherNames>Carobbio S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0065-2598</gtr:issn><gtr:outcomeId>5aa422d1be8b98.94678147</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1455B948-D1BB-42D6-9EE8-14C963767301</gtr:id><gtr:title>Methods for performing lipidomics in white adipose tissue.</gtr:title><gtr:parentPublicationTitle>Methods in enzymology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/59b6e3728c2503ea027017abe00a44c7"><gtr:id>59b6e3728c2503ea027017abe00a44c7</gtr:id><gtr:otherNames>Roberts LD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0076-6879</gtr:issn><gtr:outcomeId>5454ab50945a63.26442030</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B4601C26-C326-45E2-AD47-6A32E7CC6DB8</gtr:id><gtr:title>Erratum: Adipose tissue fatty acid chain length and mono-unsaturation increases with obesity and insulin resistance.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5b0fe1561e92f157420919eb81c6a910"><gtr:id>5b0fe1561e92f157420919eb81c6a910</gtr:id><gtr:otherNames>Tan CY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>58b96da9bc2409.21300698</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>24C2AD65-F865-46A8-B2D9-5E2D6D80301C</gtr:id><gtr:title>Adipose tissue fatty acid chain length and mono-unsaturation increases with obesity and insulin resistance.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/21cb25ff8772b4c914687a805b1d4c64"><gtr:id>21cb25ff8772b4c914687a805b1d4c64</gtr:id><gtr:otherNames>Yew Tan C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>56cdf4db555988.55544117</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6DD3E2C3-5C46-4577-9E39-84B992CD9362</gtr:id><gtr:title>Adaptive changes of the Insig1/SREBP1/SCD1 set point help adipose tissue to cope with increased storage demands of obesity.</gtr:title><gtr:parentPublicationTitle>Diabetes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f3098d46384b300a0dd4b590e33f76cd"><gtr:id>f3098d46384b300a0dd4b590e33f76cd</gtr:id><gtr:otherNames>Carobbio S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0012-1797</gtr:issn><gtr:outcomeId>pm_16153_23_23919961</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BD8D92FE-A633-446B-A1B9-1A3DB2487207</gtr:id><gtr:title>The different shades of fat.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f78416e5a69118d3de1d9d6de0470863"><gtr:id>f78416e5a69118d3de1d9d6de0470863</gtr:id><gtr:otherNames>Peirce V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>5454ab501bde29.70937077</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F080AA89-7C6E-481A-96D4-5332759D4BE5</gtr:id><gtr:title>A Selective Sweep on a Deleterious Mutation in CPT1A in Arctic Populations.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/38135e190aec3687cd14ecc949cbbae4"><gtr:id>38135e190aec3687cd14ecc949cbbae4</gtr:id><gtr:otherNames>Clemente FJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>56cdf4dda10ce6.50407351</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1B663C44-8A33-42B8-BA8A-50F03DB15FA6</gtr:id><gtr:title>Regulation of glucose homoeostasis by brown adipose tissue.</gtr:title><gtr:parentPublicationTitle>The lancet. Diabetes &amp; endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f78416e5a69118d3de1d9d6de0470863"><gtr:id>f78416e5a69118d3de1d9d6de0470863</gtr:id><gtr:otherNames>Peirce V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2213-8587</gtr:issn><gtr:outcomeId>5454ab506dcea5.03098009</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>85901A52-A55A-45FF-BA6F-957754B0DE05</gtr:id><gtr:title>Sphingolipids and glycerophospholipids - The &amp;quot;ying and yang&amp;quot; of lipotoxicity in metabolic diseases.</gtr:title><gtr:parentPublicationTitle>Progress in lipid research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/89fbfd715cfa7a742a5e3d8de973a98c"><gtr:id>89fbfd715cfa7a742a5e3d8de973a98c</gtr:id><gtr:otherNames>Rodriguez-Cuenca S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0163-7827</gtr:issn><gtr:outcomeId>5a2fcd2781d208.79983410</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BB/H002731/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>